Site search

Clear filter
2879 results for '' found
Functional Connectivity-informed Individualised Transcranial Magnetic Stimulation Therapy for Anorexia Nervosa (FUNCTIAN) – An Open-Label Proof of Concept Study (ACTRN12623001146684)
Functional Connectivity-informed Individualised Transcranial Magnetic Stimulation Therapy for Anorexia Nervosa (FUNCTIAN) – An Open-Label Proof of Concept Study (ACTRN12623001146684)
/
FRONTIER-AP: Randomized controlled trial of endovascular versus standard medical therapy for stroke with medium sized vessel occlusion (ACTRN12621001746820)
FRONTIER-AP: Randomized controlled trial of endovascular versus standard medical therapy for stroke with medium sized vessel occlusion (ACTRN12621001746820)
/
Frailty response in patients with aortic stenosis undergoing transcatheter aortic valve implantation; a cluster randomised controlled trial (ACTRN12624000318583)
Frailty response in patients with aortic stenosis undergoing transcatheter aortic valve implantation; a cluster randomised controlled trial (ACTRN12624000318583)
/
A randomised, double-blind, multicentre, Active-controlled, parallel-group study to evaluate the efficacy and safety of fluticasone proprionate/alburterol sulfate fixed-dose combination on severe
A randomised, double-blind, multicentre, Active-controlled, parallel-group study to evaluate the efficacy and safety of fluticasone proprionate/alburterol sulfate fixed-dose combination on severe
/
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF Class 1 and Class 2 alterations, in participants with cancer harboring BRAF alterations (NCT05503797)
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF Class 1 and Class 2 alterations, in participants with cancer harboring BRAF alterations (NCT05503797)
/
A multi-centre, randomised, multi-arm, adaptive platform trial in people with or without cystic fibrosis Finding the Optimal Regimen for Mycobacterium abscessus Treatment [FORMaT] (NCT04310930)
A multi-centre, randomised, multi-arm, adaptive platform trial in people with or without cystic fibrosis Finding the Optimal Regimen for Mycobacterium abscessus Treatment [FORMaT] (NCT04310930)
/
A Pilot Study of the Efficacy and Safety of Faecal Microbiota Transplant for the Treatment of Immune Checkpoint Inhibitor Colitis (ACTRN12624000120572)
A Pilot Study of the Efficacy and Safety of Faecal Microbiota Transplant for the Treatment of Immune Checkpoint Inhibitor Colitis (ACTRN12624000120572)
/
Frailty-stratified, randomised controlled Bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma (TI-NDMM) – the FRAIL-M study (ACTRN12619001199101)
/
Fludrocortisone administration in aneurysmal subarachnoid haemorrhage (NCT06409364)
/
Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries (NCT06293469)
Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries (NCT06293469)
/
47 48 49 50 51